Kevin Statz

Kevin Statz has a diverse work experience in the pharmaceutical industry. Kevin started their career as a Pharmaceutical Sales Representative at Abbott in 1998, where they achieved a top 20% national ranking despite facing managed care barriers. Kevin then worked as an Adjunct Professor at Florida International University, teaching chemistry and biology courses while completing their Master's in Anatomy & Physiology.

Kevin went on to work at Johnson & Johnson, where they held various roles such as Sr. Hospital Representative and District Sales Manager for the OrthoBiotech Nephrology Franchise. Kevin was responsible for developing new customer bases and leading teams to achieve significant sales growth. Kevin also served as the Manager of Sales Training for the OrthoBiotech Hospital & Surgery Franchise, where they facilitated the training of over 250 sales representatives.

In 2009, Kevin joined Alkermes as the Managed Markets Marketing and Strategy Lead, focusing on the VIVITROL Franchise. Kevin led marketing and strategy efforts for various groups and played a crucial role in core physician, digital, and patient marketing.

Kevin then moved to Collegium Pharmaceutical, Inc. in 2015 as the Director of Marketing and Strategy. Here, they developed commercial capabilities and prepared the organization for the launch of their first medication. Kevin'sresponsibilities included market research, strategy development, and promotional tactics across multiple channels.

Most recently, Kevin has been working at Anika Therapeutics as the Executive Director of Global Marketing since 2017. Further details about this role were not provided.

Kevin Statz received a Bachelor's Degree in Biochemistry and Biology from Florida State University, where they studied from 1989 to 1996. Kevin later pursued a Master of Business Administration (M.B.A.) with a concentration on Finance, Valuation, and Private Equity at the MIT Sloan School of Management from 2012 to 2014.